Community post
Ella Balasa, who received phage therapy in 2019 (which she wrote about in Capsid & Tail earlier this year), has her own column in Cystic Fibrosis News Today called This Lung Life. Her newest article describes her participation in an FDA panel, where she gave feedback on regulatory considerations that could increase access to individualized phage treatments.
Topics
| Source | Capsid & Tail #67 |
|---|